Remind yourself of key themes from the MAPS Madrid meeting with this Day 1 report authored meeting media partner, the Publication Plan. If you weren’t able to attend this year’s meeting, catch up on what you missed!
In this podcast, we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling.
In this podcast, we speak with Jill Donahue, author of the recently published (free!) book, “A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders” about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry.
This e-Learning module will enable learners to define principles of and adopt an integrated approach to orchestrating omnichannel Company-led Education, identify stakeholder segmentation and associated learning journeys for use in content development, use the associated outcomes and insights to deliver and improve omnichannel medical education, while complying with industry regulations as well as company governance and oversight policies.
In this podcast, we talk about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable.
Early involvement of Medical Affairs can be valuable to R&D by providing medical insights from HCPs to influence the TPP, go/no go decision, and optimize the clinical development program. Some biopharma organizations are hiring pipeline MSLs reporting to a Medical Affairs lead within the R&D organization to support clinical trial enrollment efforts and bring the voice of the customer to asset decisions. Defining disease areas of interest is also crucial, involving understanding diseases for which an emerging technology may have an application and determining the existing unmet medical need. Additionally, clarifying the patient journey informs the TPP, clinical feasibility of planned trials, and selection of clinical trial endpoints.
During the webinar, we will discuss considerations for the appropriate structure, resources, and timing to get Medical Affairs involved early enough in the process to optimize clinical development plans informed by medical customer insights. We will also have a dialogue around how early involvement of Medical Affairs can influence which indications should be pursued for a label versus investigator-initiated research.
The more the industry evolves, the more compliance teams need to keep pace with this change. The good news is there are 6 actionable steps you can make to stay ahead of the dynamic pressure.
In this podcast, we explore machine learning as a way to get information about an audience.
The online webinar titled "Medical Operations: Making the Strategy Work" will delve into the critical aspects of how medical operations are instrumental in realizing overall medical strategy. The webinar will highlight the role of medical operations as an innovation hub, showcasing its significance in driving advancements within Medical Affairs. Additionally, the session will emphasize the importance of collaborative partnerships across the entire company, illustrating how such collaborations enable the achievement of better patient outcomes. Attendees can expect valuable insights into the strategic functions of medical operations and how they contribute to the overall success of Medical Affairs.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.